Next Article in Journal
Biofilms in Endodontics—Current Status and Future Directions
Next Article in Special Issue
Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia
Previous Article in Journal
Electronegative Low-Density Lipoprotein L5 Impairs Viability and NGF-Induced Neuronal Differentiation of PC12 Cells via LOX-1
Previous Article in Special Issue
Tricetin Induces Apoptosis of Human Leukemic HL-60 Cells through a Reactive Oxygen Species-Mediated c-Jun N-Terminal Kinase Activation Pathway
Open AccessArticle

Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer

by 1,†, 2,†, 2,3 and 2,*
1
Department of Food Biotechnology, Gachon University, Kyungji-Do 13120, Korea
2
Department of Food Biotechnology, Division of Bioindustry, Silla University, Busan 46958, Korea
3
The Research Center for Extremophiles & Marine Microbiology, Silla University, Busan 46958, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2017, 18(8), 1746; https://doi.org/10.3390/ijms18081746
Received: 30 June 2017 / Revised: 1 August 2017 / Accepted: 4 August 2017 / Published: 11 August 2017
(This article belongs to the Special Issue Alterations to Signalling Pathways in Cancer Cells)
Colon cancer is one of the most common types of cancer, and it has recently become a leading cause of death worldwide. Among colon cancers, the v-ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutated form is notorious for its non-druggable features. Cetuximab, a monoclonal antibody that binds to the epidermal growth factor receptor, has been introduced as an antitumor therapy; however, secondary resistance and side effects significantly limit its effective use in these cancers. In this study, we prepared Phellinuslinteus on germinated brown rice (PBR) extracts to increase the sensitivity of KRAS-mutated colon cancers to cetuximab. The combined treatment of PBR extract and cetuximab suppressed SW480 cell viability/proliferation, with the cells exhibiting altered cellular morphology and clonogenic potential. AnnexinV–fluorescein isothiocyanate/propidium iodide–stained flow cytometry and Western blotting were performed, and PBR extract combined with cetuximab treatment increased apoptosis of the SW480 cells and suppressed their KRAS protein expression. The potential of PBR as a synergistic anticancer agent was further investigated in a tumor-xenografted mouse model. Tumor growth was significantly suppressed with PBR extract and cetuximab co-treatment. In conclusion, PBR increased the sensitivity of KRAS-mutated colon cancer cells to cetuximab, which indicates the potential use of PBR as a medical food against colon cancer. View Full-Text
Keywords: Phellinuslinteus; colorectal cancer; Kirsten rat sarcoma viral oncogene homolog; cetuximab; drug sensitivity; β-glucan Phellinuslinteus; colorectal cancer; Kirsten rat sarcoma viral oncogene homolog; cetuximab; drug sensitivity; β-glucan
Show Figures

Graphical abstract

MDPI and ACS Style

Park, H.-J.; Park, J.-B.; Lee, S.-J.; Song, M. Phellinus linteus Grown on Germinated Brown Rice Increases Cetuximab Sensitivity of KRAS-Mutated Colon Cancer. Int. J. Mol. Sci. 2017, 18, 1746.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop